<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: We observed that a significant proportion of patients with <z:hpo ids='HP_0000704'>periodontitis</z:hpo> have elevated serum levels of beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi>-I-dependent anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi> (anti-CL) </plain></SENT>
<SENT sid="1" pm="."><plain>These prothrombotic autoantibodies, commonly found to be elevated in patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> and the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, are associated with adverse pregnancy outcomes, such as fetal <z:mpath ids='MPATH_624'>involution</z:mpath>, <z:e sem="disease" ids="C0728731" disease_type="Disease or Syndrome" abbrv="">prematurity</z:e>, and <z:hpo ids='HP_0001518'>low birth weight</z:hpo>, and with cardiovascular sequelae, such as <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, <z:hpo ids='HP_0001297'>stroke</z:hpo>, and <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Anti-CL is known to promote <z:mp ids='MP_0001863'>vascular inflammation</z:mp> and <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We measured serum levels of markers of <z:mp ids='MP_0001863'>vascular inflammation</z:mp>, including soluble intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule (sICAM)-1, soluble vascular cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule (sVCAM)-1, and sE-selectin, in 190 subjects with generalized aggressive or <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0000704'>periodontitis</z:hpo> and in 90 periodontally healthy subjects </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: sVCAM-1 and sE-selectin levels were significantly higher in patients with elevated anti-CL (&gt;15 U/ml) </plain></SENT>
<SENT sid="5" pm="."><plain>This relationship also was observed in the never-smoker subset of subjects, even after correction for demographic and periodontal variables </plain></SENT>
<SENT sid="6" pm="."><plain>Within the diagnostic categories, sICAM-1, sVCAM-1, and sE-selectin were significantly higher in generalized aggressive <z:hpo ids='HP_0000704'>periodontitis</z:hpo> patients who had elevated anti-CL compared to those with <z:mpath ids='MPATH_458'>normal</z:mpath> anti-CL </plain></SENT>
<SENT sid="7" pm="."><plain>Statistical correction for demographic and periodontal variables indicated that elevated anti-CL remained significantly associated with increased sVCAM-1 and sE-selectin in generalized aggressive <z:hpo ids='HP_0000704'>periodontitis</z:hpo> patients </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Systemic markers of <z:mp ids='MP_0001863'>vascular inflammation</z:mp> in patients with aggressive <z:hpo ids='HP_0000704'>periodontitis</z:hpo> are associated with elevated levels of anti-CL </plain></SENT>
<SENT sid="9" pm="."><plain>We hypothesize that a subset of <z:hpo ids='HP_0000704'>periodontitis</z:hpo> patients with elevated <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> could represent a subgroup at increased risk for obstetrical and cardiovascular sequelae </plain></SENT>
</text></document>